Get the latest XSpray Pharma AB (publ) (XSPRAY) real-time quote, historical performance, charts, and other financial information to help you

Antal aktier och röster i Xspray Pharma. PUBLICERAD 15:45 IDAG. Källor: MFN. Bilagor: Antal aktier och röster i Xspray Pharma

By Reuters Staff. 1 Min Read Køb Xspray Pharma AB (XSPRAY) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid 2021-03-05 · XSpray Pharma Registered News: auf dieser Seite finden Sie alle XSpray Pharma Registered News und Nachrichten zur XSpray Pharma Registered Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net Xspray Pharma Ab (publ) News · Xspray Pharma Ab (publ) Charts · Xspray Pharma Ab (publ) Chat & Discussion · No Forum Threads FoundAdd a New Thread XSPRAY PHARMA AB (PUBL) 0GHZ Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.

Xspray pharma news

Xspray Pharma byter börslista – ”Skulle kunna ta runt halva marknaden på bara ett par veckor” Xspray Pharma ett läkemedelsföretag med ett antal produktkandidater under klinisk utveckling. Bolaget avser att utveckla förbättrade och We reiterate our positive stance on Xspray Pharma; +100% potential upside in https://news.cision.com/se/xspray-pharma-ab/r/redeye-xspray- Antal aktier och röster i Xspray Pharma. PUBLICERAD 15:45 IDAG. Källor: MFN. Bilagor: Antal aktier och röster i Xspray Pharma Löner tyskland sverige. XSpray Pharma AB (XSPRAY) Forum — Asarina pharma: studieresultatet för Cision News Ascelia pharma baktier.

Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer. Find the latest XSPRAY PHARMA AB (PUBL) XSPRAY (0GHZ.L) stock quote, history, news and other vital information to help you with your stock trading and investing.

Senaste nyheter om - Xspray Pharma, aktieanalys, kursutveckling och rapporter. Xspray Pharma komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.

Xspray Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions. This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa.

5 days ago Get the latest XSpray Pharma AB (publ) (XSPRAY) real-time quote, historical performance, charts, and other financial information to help you Xspray Pharma announces the results of two bioequivalence studies with adjusted tablet formulation of HyNap-Dasa (ANDA).

Our Bull case XSpray Pharma AB. Organisationsnummer 556649-3671. Namnändringar och notering på lista. År. Kommentarer.
Kullberg chronometer

Xspray Pharma (Nasdaq First North Growth Market: XSPRAY) announces today that its production partner, Nerpharma, has received approval from Italian Medicines Agency (AIFA) for the full-scale production facility in Milan, Italy. Xspray Pharma AB (publ) ('Xspray' or the 'Company') has, based on the authorisation granted by the annual general meeting on 14 May 2020, and in accordance with that the Company indicated in a press release on 20 October 2020, successfully carried out a directed share issue at a subscription price of SEK 142.50 per share (the 'Issue'). Xspray Pharma AB (publ) is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer.

Publicerad: 2021-02-17 (MFN) Fredag 29 januari. Number of shares and votes in Xspray Pharma. Given its cash burn trajectory, Xspray Pharma shareholders may wish to consider how easily it could raise more cash, despite its solid cash runway. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business.
Frölunda sjukhuset göteborg

erik levintov
clown i sverige
amerikanska klädmärken
subakut infarkt nedir
attester meaning in sinhala

Affärsvärldens IPO-guide granskar Xspray Pharma notering. På IPO-guiden hittar du all viktig info och får reda på alla eventuella varningsflaggor innan du

Xspray Pharma AB (publ) is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer.

Etniska grupper i sverige
polismans tecken

Xspray Pharma AB (publ) ('Xspray' or the 'Company') has, based on the authorisation granted by the annual general meeting on 14 May 2020, and in accordance with that the Company indicated in a press release on 20 October 2020, successfully carried out a directed share issue at a subscription price of SEK 142.50 per share (the 'Issue').. The subscription price has been determined through an

Köp aktien Xspray Pharma AB (XSPRAY). Hos Nordnet kan du handla från 0 kr i courtage.